Burke Steven Keith 4
4 · Akebia Therapeutics, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2025-03-03$1.83/sh−7,144$13,074→ 809,090 total
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.